(Press-News.org) Chicago, Illinois (Embargoed until 10:05 a.m. CDT, Tuesday, June 27, 2023)—Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals with obesity respond differently to food cues than those in normal-weight individuals, making the neuroreceptors a prime target for obesity treatments and therapy. This research, presented at the Society of Nuclear Medicine and Molecular Imaging 2023 Annual Meeting, contributes to the understanding of the fundamental mechanisms underlying obesity and offers valuable insights into potential medical interventions.
Worldwide, more than one billion people are obese. The global obesity epidemic poses a major challenge for health care systems worldwide, and the search for interventions to achieve sustainable weight loss is a high priority. By investigating biological and behavioral mechanisms in individuals with obesity, scientists are seeking to identify potential pathways for treatments and interventions.
“The brain’s cholinergic system is a unique area of interest when it comes to studying obesity,” said Swen Hesse, MD, clinical scientist and professor in the Department of Nuclear Medicine at the University of Leipzig in Leipzig, Germany. “Cholinergic changes in the brain’s reward and attentional networks seem to play an important role in how people decide what foods are most desirable, or salient. In our study, we aimed to measure changes in α4β2* nicotinic acetylcholine receptors found in the cholinergic system in response to high-caloric food cues.”
In the study, 15 individuals with obesity and 16 normal-weight controls underwent PET/MRI with 18F-flubatine twice on separate days, once while in a resting state and once while viewing food pictures. Total distribution volume of 18F-flubatine was estimated, and a visual analog scale was used to assess states of hunger/satiety, appetite, disinhibition, craving and taste. Eating behavior was also measured using the Three-Factor Eating Questionnaire (TFEQ).
In the resting state, no significant difference in total distribution volume of 18F-flubatine was noted between the participants with obesity and normal-weight controls. While viewing photos of food, however, the total distribution volume of 18F-flubatine was higher in the obese compared with normal-weight controls in the thalamus of the brain, particularly in those with a higher TFEQ score.
For normal-weight controls there was a stronger connectivity to the dorsal attention network of the brain when viewing food cues, whereas for participants with obesity, a stronger connectivity was found with the salience network. Finally, analyses of the total volume distribution and different behavioral measures showed significant correlation between total volume distribution in the hypothalamus and measure for satiety in normal-weight controls. In participants with obesity there was a significant correlation with measures of disinhibition and the nucleus accumbens.
“We anticipate that the results of our study will pave the way for novel drug treatments and behavioral interventions to effectively combat obesity worldwide,” noted, Osama Sabri, MD, PhD, professor, director, and chairman of the Department of Nuclear Medicine at the University of Leipzig. “In addition, the imaging technology utilized in this study holds promise for identifying biomarkers that can aid in patient stratification and facilitate personalized medicine approaches in the near future.”
Abstract 911. “Central α4β2 nicotinic acetylcholine receptors encode salience processing in human obesity,” Swen Hesse, Michael Rullmann, Eva Schweickert de Palma, Tilman Günnewig, Julia Luthardt, Georg-Alexander Becker, Franziska Ruth Zientek, Philipp M. Meyer, Sarah Martin, Marianne Patt and Osama Sabri, Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; Mohammed K. Hankir, Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany; Anja Hilbert, Department of Psychosomatic Medicine and Psychotherapy, Integrated Research and Treatment Center Adiposity Diseases, Behavioral Medicine Research Unit, Leipzig, Germany; Matthias Blüher, Medical Department III, Endocrinology, Nephrology, Rheumatology, University Medical Center Leipzig, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, University of Leipzig, Leipzig, Germany.
Link to Session
###
All 2023 SNMMI Annual Meeting abstracts can be found online.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
END
Molecular imaging identifies brain changes in response to food cues; offers insight into obesity interventions
2023-06-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Flexible, supportive company culture makes for better remote work
2023-06-27
The pandemic made remote work the norm for many, but that doesn’t mean it was always a positive experience. Remote work can have many advantages: increased flexibility, inclusivity for parents and people with disabilities, and work-life balance. But it can also cause issues with collaboration, communication, and the overall work environment.
New research from the Georgia Institute of Technology used data from the employee review website Glassdoor to determine what made remote work successful. Companies that catered to employees’ interests, ...
BU study unpacks how medical systems harm the intersex community
2023-06-27
(Boston)— Intersex people’s (people whose sex characteristics do not fit within the strict binary categorizations of male or female) healthcare has received a lot of media attention recently, particularly with the uptick in anti-transgender legislation, which often also targets this community. Discrimination and mistreatment in social and medical settings, largely due to the stigma of not conforming to binary views of sex, results in many intersex individuals experiencing isolation, secrecy and shame, which can have a lasting impact on their mental health.
A new study from researchers at Boston University Chobanian & Avedisian School of Medicine highlights the need ...
Follow the leader: Researchers identify mechanism of cancer invasion
2023-06-27
UNIVERSITY PARK, Pa. — A cancerous tumor is the accumulation of cells uncontrollably dividing, some of which can invade other parts of the body. The process is difficult to predict in detail, and eradicating the cells poses even greater difficulty. Now, a Penn State-led research team has revealed how the exodus initiates, shedding light on a potential therapeutic target to halt the invasion and providing a prognostic marker to help clinicians select the best treatment option.
They published their findings on June 26 in the Proceedings of the National Academy of Sciences.
“Cancer cells don’t randomly detach from the primary tumor and disseminate ...
New enzyme could aid anticancer drug development
2023-06-27
HOUSTON – (June 27, 2023) – Many of the drugs we use to treat cancer and infectious disease are ⎯ or derive from ⎯ natural products, but it’s difficult to know exactly how nature assembles them.
Retracing nature’s steps, Rice University chemical engineer Xue Gao and her team mapped out the full series of enzyme-powered reactions a marine fungus uses to produce 21R-citrinadin A, a complex molecule with anticancer properties.
In the process, Gao and her collaborators identified a new enzyme, CtdY, which is the only one ...
Penn State researchers develop digital test to directly measure HIV viral load
2023-06-27
UNIVERSITY PARK, Pa. — A milliliter of blood contains about 15 individual drops. For a person with human immunodeficiency virus (HIV), each drop of blood could contain anywhere from fewer than 20 copies of the virus to more than 500,000 copies. Called the viral load, this is what is measured to allow clinicians to understand how patients are responding to anti-viral medications and monitor potential progression.
The time-consuming viral load testing needs to be repeated several times as a patient undergoes treatment. Now, a Penn State research team has developed a time and cost-efficient digital assay that can directly measure the presence of HIV in ...
The more stakeholders are included in policy planning, the better those policies protect them
2023-06-27
Having a seat at the table, and voices heard, makes a world of difference when it comes to natural resources. It sounds intuitive, but experts didn’t have enough data to prove it until now.
A team of researchers from across the country pored over 108 groundwater management plans in California to see how well they protect stakeholders like domestic well users, farmers and ecosystems. They found that the plans that incorporated stakeholder input offered greater protection from groundwater depletion. Unfortunately, only 9% of the sustainability plans integrated these users in a comprehensive manner.
The findings have broad implications for resource management, both in California and ...
Penn State researchers use ultrasound to control orientation of small particles
2023-06-27
UNIVERSITY PARK, Pa. — Acoustic waves may be able to control how particles sort themselves. While researchers have been able to separate particles based on their shape — for example, bacteria from other cells — for years, the ability to control their movement has remained a largely unsolved problem, until now. Using ultrasound technology and a nozzle, Penn State researchers have separated, controlled and ejected different particles based on their shape and various properties.
They ...
Fondant: Where baking and thermodynamics mix
2023-06-27
WASHINGTON, June 27, 2023 – With their unique appearance, texture, and mouthfeel, fondants have intrigued bakers and physicists for years. They present an appetizing enigma in the world of confectionery, an intriguing combination of sugar, water, and heat that, when manipulated correctly, yields a delectably creamy product.
Researchers from the Max Planck Institute for Polymer Research and Technische Universität Berlin studied the kinetic and thermodynamic processes of sugar crystallization in the making of fondant. In Physics of Fluids, by AIP Publishing, they combined a controlled kneading machine with light microscopy ...
Prevalence of iron deficiency, iron-deficiency anemia in females ages 12-21
2023-06-27
About The Study: Among 12- to 21-year-old U.S. females between 2003 and 2020, iron deficiency affected almost 40% and iron deficiency anemia affected 6%, with variation by the ferritin or hemoglobin thresholds used. Menstruation was a risk factor for both, but more than one-quarter of premenarchal individuals had iron deficiency.
Authors: Angela C. Weyand, M.D., of the University of Michigan Medical School in Ann Arbor, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.8020)
Editor’s Note: Please see the article for ...
Team proposes a new view on euchromatin in the cell
2023-06-27
In their paper the team discusses their novel view of euchromatin in the cell and shows how the revealed organization is relevant to genome functions. “Our ultimate goal is to reveal how genomic information is searched and read out in living cells,” said Kazuhiro Maeshima, a leading author and a professor with the National Institute of Genetics and SOKENDAI, Japan.
Chromatin describes the combination of DNA and proteins in the cells of humans and other eukaryotes. According to typical textbook models, chromatin occurs in two forms— euchromatin, that is less condensed and can be transcribed, and heterochromatin, that is more condensed and usually not transcribed. ...